Logo-jcvtr

J Cardiovasc Thorac Res. 2017;9(4): 183-190. doi: 10.15171/jcvtr.2017.32
PMID: 29391930        PMCID: PMC5787329

Original Article

The effects of sodium butyrate and inulin supplementation on angiotensin signaling pathway via promotion of Akkermansia muciniphila abundance in type 2 diabetes; A randomized, double-blind, placebo-controlled trial

Neda Roshanravan 1, Reza Mahdavi 2, Effat Alizadeh 3, Abed Ghavami 4, Yalda Rahbar Saadat 2, Naimeh Mesri Alamdari 5, Shahriar Alipour 6, Mohammad Reza Dastouri 7, Alireza Ostadrahimi 2 *

Cited by CrossRef: 51

1- Lee J, Lee J, Lee A, Jo S, Park C, Han D, Eun C. Impact of short-chain fatty acid supplementation on gut inflammation and microbiota composition in a murine colitis model. The Journal of Nutritional Biochemistry. 2022;101:108926 [Crossref]
2- Wisniewski P, Dowden R, Campbell S. Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota. Nutrients. 2019;11(1):117 [Crossref]
3- Park Y, Lee S, Kang M, Kim B, Lee M, Jung S, Yoon J, Cho H, Lee E, Yang S, Seo J, Kim H, Suh D, Shin Y, Kim K, Ahn K, Hong S. Imbalance of GutStreptococcus,Clostridium, andAkkermansiaDetermines the Natural Course of Atopic Dermatitis in Infant. Allergy Asthma Immunol Res. 2020;12(2):322 [Crossref]
4- Kotrova A, Shishkin A, Ermolenko E, Saraykina D, Volovnikova V. Gut microbiota and hypertension. Arter gipertenz. 2021;26(6):620 [Crossref]
5- Lakshmanan A, Murugesan S, Al Khodor S, Terranegra A. The potential impact of a probiotic: Akkermansia muciniphila in the regulation of blood pressure—the current facts and evidence. J Transl Med. 2022;20(1) [Crossref]
6- Yamaguchi A, Teratani T, Chu P, Suzuki T, Taniki N, Mikami Y, Shiba S, Morikawa R, Amiya T, Aoki R, Kanai T, Nakamoto N. Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented Mice. Hepatol Commun. 2021;5(9):1555 [Crossref]
7- Baumann A, Jin C, Brandt A, Sellmann C, Nier A, Burkard M, Venturelli S, Bergheim I. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis. Nutrients. 2020;12(4):951 [Crossref]
8- Xu Y, Wang N, Tan H, Li S, Zhang C, Feng Y. Function of Akkermansia muciniphila in Obesity: Interactions With Lipid Metabolism, Immune Response and Gut Systems. Front Microbiol. 2020;11 [Crossref]
9- Xue C, Li G, Gu X, Su Y, Zheng Q, Yuan X, Bao Z, Lu J, Li L. Health and Disease: Akkermansia muciniphila , the Shining Star of the Gut Flora . Research. 2023;6 [Crossref]
10- Smiljanec K, Lennon S. Sodium, hypertension, and the gut: does the gut microbiota go salty?. American Journal of Physiology-Heart and Circulatory Physiology. 2019;317(6):H1173 [Crossref]
11- Garcia-Manieri J, Correa V, Backes E, de Sá-Nakanishi A, Bracht L, Comar J, Corrêa R, Peralta R, Bracht A. A Critical Appraisal of the Most Recent Investigations on the Hepatoprotective Action of Brazilian Plants. Plants. 2022;11(24):3481 [Crossref]
12- Sitkin S, Vakhitov T, Pokrotnieks J. Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes. Neurogastroenterology Motil. 2021;33(1) [Crossref]
13- Luo X, Han Z, Kong Q, Wang Y, Mou H, Duan X. Clostridium butyricum Prevents Dysbiosis and the Rise in Blood Pressure in Spontaneously Hypertensive Rats. IJMS. 2023;24(5):4955 [Crossref]
14- Golzarand M, Bahadoran Z, Mirmiran P, Azizi F. Inulin intake and the incidence of cardiometabolic diseases: a prospective cohort study. Food Funct. 2022;13(20):10516 [Crossref]
15- Merkevičius K, Kundelis R, Maleckas A, Veličkienė D. Microbiome Changes after Type 2 Diabetes Treatment: A Systematic Review. Medicina. 2021;57(10):1084 [Crossref]
16- Rao M, Gao C, Xu L, Jiang L, Zhu J, Chen G, Law B, Xu Y. Effect of Inulin-Type Carbohydrates on Insulin Resistance in Patients with Type 2 Diabetes and Obesity: A Systematic Review and Meta-Analysis. Journal of Diabetes Research. 2019;2019:1 [Crossref]
17- Guo J, Zhang M, Wang H, Li N, Lu Z, Li L, Hui S, Xu H. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice . Journal of Food Biochemistry. 2022;46(5) [Crossref]
18- Zheng J, Zhang J, Guo Y, Cui H, Lin A, Hu B, Gao Q, Chen Y, Liu H. Improvement on metabolic syndrome in high fat diet-induced obese mice through modulation of gut microbiota by sangguayin decoction. Journal of Ethnopharmacology. 2020;246:112225 [Crossref]
19- Shah B, Li B, Al Sabbah H, Xu W, Mráz J. Effects of prebiotic dietary fibers and probiotics on human health: With special focus on recent advancement in their encapsulated formulations. Trends in Food Science & Technology. 2020;102:178 [Crossref]
20- Qin Y, Wang L, Yang X, Xu Y, Fan G, Fan Y, Ren J, An Q, Li X. Inulin: properties and health benefits. Food Funct. 2023;14(7):2948 [Crossref]
21- Eslick S, Thompson C, Berthon B, Wood L. Short-chain fatty acids as anti-inflammatory agents in overweight and obesity: a systematic review and meta-analysis. 2022;80(4):838 [Crossref]
22- Satoh T, Sasaki K. 3-Hydroxybutyrate could serve as a principal energy substrate for human microbiota. Medical Hypotheses. 2024;182:111217 [Crossref]
23- Kim K, Tiffany E, Lee J, Oh A, Jin H, Kim J, Lee J, Nam M, Hong S, Park S, Koh H, Kim B, Lee Y, Lee D. Genome-wide multi-omics analysis reveals the nutrient-dependent metabolic features of mucin-degrading gut bacteria. Gut Microbes. 2023;15(1) [Crossref]
24- Rezasoltani S, Azizmohammad Looha M, Asadzadeh Aghdaei H, Jasemi S, Sechi L, Gazouli M, Sadeghi A, Torkashvand S, Baniali R, Schlüter H, Zali M, Feizabadi M. 16S rRNA sequencing analysis of the oral and fecal microbiota in colorectal cancer positives versus colorectal cancer negatives in Iranian population. Gut Pathog. 2024;16(1) [Crossref]
25- Qu H, Song L, Zhang Y, Gao Z, Shi D. The Effect of Prebiotic Products on Decreasing Adiposity Parameters in Overweight and Obese Individuals: A Systematic Review and Meta- Analysis. CMC. 2020;28(2):419 [Crossref]
26- Yue C, Chu C, Zhao J, Zhang H, Chen W, Zhai Q. Dietary strategies to promote the abundance of intestinal Akkermansia muciniphila, a focus on the effect of plant extracts. Journal of Functional Foods. 2022;93:105093 [Crossref]
27- Fan C, Xu J, Tong H, Fang Y, Chen Y, Lin Y, Chen R, Chen F, Wu G. Gut–brain communication mediates the impact of dietary lipids on cognitive capacity. Food Funct. 2024;15(4):1803 [Crossref]
28- Nie Q, Chen H, Hu J, Fan S, Nie S. Dietary compounds and traditional Chinese medicine ameliorate type 2 diabetes by modulating gut microbiota. Critical Reviews in Food Science and Nutrition. 2019;59(6):848 [Crossref]
29- Verhoog S, Taneri P, Roa Díaz Z, Marques-Vidal P, Troup J, Bally L, Franco O, Glisic M, Muka T. Dietary Factors and Modulation of Bacteria Strains of Akkermansia muciniphila and Faecalibacterium prausnitzii: A Systematic Review. Nutrients. 2019;11(7):1565 [Crossref]
30- da Silva J, Nagata C. Efficacy of prebiotics in promoting a healthy gut microbiota in adults and elderly persons in the community. Nutrire. 2021;46(2) [Crossref]
31- von Süßkind-Schwendi M, Dötsch A, Haberland V, Ferrario P, Krüger R, Louis S, Döring M, Graf D. Addition of soluble fiber to standard purified diets is important for gut morphology in mice. Sci Rep. 2023;13(1) [Crossref]
32- Talukdar J, Cooper M, Lyutvyn L, Zeraatkar D, Ali R, Berbrier R, Janes S, Ha V, Darling P, Xue M, Chu A, Chowdhury F, Harnack H, Huang L, Malik M, Powless J, Lavergne F, Zhang X, Ehrlich S, Jenkins D, Sievenpiper J, Banfield L, Mbuagbaw L, de Souza R. The effects of inulin-type fructans on cardiovascular disease risk factors: systematic review and meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition. 2024;119(2):496 [Crossref]
33- da Silva Borges D, Fernandes R, Thives Mello A, da Silva Fontoura E, Soares dos Santos A, Santos de Moraes Trindade E. Prebiotics may reduce serum concentrations of C-reactive protein and ghrelin in overweight and obese adults: a systematic review and meta-analysis. 2019; [Crossref]
34- Anwar F, Alhayyani S, Al‐Abbasi F, Nadeem M, Kumar V. Pharmacological role of Vitamin C in stress‐induced cardiac dysfunction via alteration in Gut microbiota. J Biochem & Molecular Tox. 2022;36(4) [Crossref]
35- Li Z, Ke H, Wang Y, Chen S, Liu X, Lin Q, Wang P, Chen Y. Global trends in Akkermansia muciniphila research: A bibliometric visualization. Front Microbiol. 2022;13 [Crossref]
36- Marzano M, Fosso B, Colliva C, Notario E, Passeri D, Intranuovo M, Gioiello A, Adorini L, Pesole G, Pellicciari R, Moschetta A, Gadaleta R. Farnesoid X receptor activation by the novel agonist TC-100 (3α, 7α, 11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid) preserves the intestinal barrier integrity and promotes intestinal microbial reshaping in a mouse model of obstructed bile acid flow. Biomedicine & Pharmacotherapy. 2022;153:113380 [Crossref]
37- Rodrigues V, Elias-Oliveira J, Pereira Í, Pereira J, Barbosa S, Machado M, Carlos D. Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes. Front Immunol. 2022;13 [Crossref]
38- Tawfick M, Xie H, Zhao C, Shao P, Farag M. Inulin fructans in diet: Role in gut homeostasis, immunity, health outcomes and potential therapeutics. International Journal of Biological Macromolecules. 2022;208:948 [Crossref]
39- Wagenaar C, van de Put M, Bisschops M, Walrabenstein W, de Jonge C, Herrema H, van Schaardenburg D. The Effect of Dietary Interventions on Chronic Inflammatory Diseases in Relation to the Microbiome: A Systematic Review. Nutrients. 2021;13(9):3208 [Crossref]
40- Paul P, Kaul R, Abdellatif B, Arabi M, Upadhyay R, Saliba R, Sebah M, Chaari A. The Promising Role of Microbiome Therapy on Biomarkers of Inflammation and Oxidative Stress in Type 2 Diabetes: A Systematic and Narrative Review. Front Nutr. 2022;9 [Crossref]
41- Chu N, Chan J, Chow E. A diet high in FODMAPs as a novel dietary strategy in diabetes?. Clinical Nutrition. 2022;41(10):2103 [Crossref]
42- Corb Aron R, Abid A, Vesa C, Nechifor A, Behl T, Ghitea T, Munteanu M, Fratila O, Andronie-Cioara F, Toma M, Bungau S. Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of Akkermansia muciniphila as a Key Gut Bacterium. Microorganisms. 2021;9(3):618 [Crossref]
43- Vander Wyst K, Ortega‐Santos C, Toffoli S, Lahti C, Whisner C. Diet, adiposity, and the gut microbiota from infancy to adolescence: A systematic review. Obesity Reviews. 2021;22(5) [Crossref]
44- Stec A, Sikora M, Maciejewska M, Paralusz-Stec K, Michalska M, Sikorska E, Rudnicka L. Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases. IJMS. 2023;24(4):3494 [Crossref]
45- Dowden R, McGuinness L, Wisniewski P, Campbell S, Guers J, Oydanich M, Vatner S, Häggblom M, Kerkhof L. Host genotype and exercise exhibit species-level selection for members of the gut bacterial communities in the mouse digestive system. Sci Rep. 2020;10(1) [Crossref]
46- Sastre M, Cimbalo A, Mañes J, Manyes L. Gut Microbiota and Nutrition: Strategies for the Prevention and Treatment of Type 2 Diabetes. Journal of Medicinal Food. 2024;27(2):97 [Crossref]
47- Ghaffari S, Abbasi A, Somi M, Moaddab S, Nikniaz L, Kafil H, Ebrahimzadeh Leylabadlo H. Akkermansia muciniphila : from its critical role in human health to strategies for promoting its abundance in human gut microbiome . Critical Reviews in Food Science and Nutrition. 2023;63(25):7357 [Crossref]
48- Khosravi Z, Hadi A, Tutunchi H, Asghari-Jafarabadi M, Naeinie F, Roshanravan N, Ostadrahimi A, Fadel A. The effects of butyrate supplementation on glycemic control, lipid profile, blood pressure, nitric oxide level and glutathione peroxidase activity in type 2 diabetic patients: A randomized triple -blind, placebo-controlled trial. Clinical Nutrition ESPEN. 2022;49:79 [Crossref]
49- Li J, Yang G, Zhang Q, Liu Z, Jiang X, Xin Y. Function of Akkermansia muciniphila in type 2 diabetes and related diseases. Front Microbiol. 2023;14 [Crossref]
50- Tindall A, Petersen K, Skulas‐Ray A, Richter C, Proctor D, Kris‐Etherton P. Replacing Saturated Fat With Walnuts or Vegetable Oils Improves Central Blood Pressure and Serum Lipids in Adults at Risk for Cardiovascular Disease: A Randomized Controlled‐Feeding Trial. JAHA. 2019;8(9) [Crossref]
51- Tian R, Yu L, Tian F, Zhao J, Chen W, Zhai Q. Effect of inulin, galacto-oligosaccharides, and polyphenols on the gut microbiota, with a focus on Akkermansia muciniphila. Food Funct. 2024; [Crossref]
52- Thompson M, DeBosch B. Maternal Fructose Diet-Induced Developmental Programming. Nutrients. 2021;13(9):3278 [Crossref]
53- Boscaini S, Leigh S, Lavelle A, García-Cabrerizo R, Lipuma T, Clarke G, Schellekens H, Cryan J. Microbiota and body weight control: Weight watchers within?. Molecular Metabolism. 2022;57:101427 [Crossref]
54- Liu S, He Y, Zhang Y, Zhang Z, Huang K, Deng L, Liao B, Zhong Y, Feng J. Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms. Gut Microbes. 2023;15(2) [Crossref]
55- KOBYLIAK N, FALALYEYEVA T, KYRIACHENKO Y, TSEYSLYER Y, KOVALCHUK O, HADILIIA O, ESLAMI M, YOUSEFI B, ABENAVOLI L, FAGOONEE S, PELLICANO R. Akkermansia muciniphila as a novel powerful bacterial player in the treatment of metabolic disorders. Minerva Endocrinol. 2022;47(2) [Crossref]
56- Álvarez-Mercado A, Navarro-Oliveros M, Robles-Sánchez C, Plaza-Díaz J, Sáez-Lara M, Muñoz-Quezada S, Fontana L, Abadía-Molina F. Microbial Population Changes and Their Relationship with Human Health and Disease. Microorganisms. 2019;7(3):68 [Crossref]
57- Gong X, Xiong L, Bi C, Zhang B. Diosmetin ameliorate type 2 diabetic mellitus by up-regulating Corynebacterium glutamicum to regulate IRS/PI3K/AKT-mediated glucose metabolism disorder in KK-Ay mice. Phytomedicine. 2021;87:153582 [Crossref]
58- Adams G. The Benefits and Risks of Probiotic, Prebiotic and Symbiotic interventions in the Care of patients with Diabetes Mellitus. IJDE. 2021;:1 [Crossref]